Vinayak Kapatral
Corporate Officer/Principal bei University of Illinois
Profil
Vinayak Kapatral is a Research Associate at the University of Illinois.
Previously, he worked as a Vice President of Business Development at Integrated Genomics, Inc. from 2000 to 2011 and as a Vice President of Business Development at IG Assets, Inc. He holds a doctorate degree from the University of Idaho.
Aktive Positionen von Vinayak Kapatral
Unternehmen | Position | Beginn |
---|---|---|
University of Illinois | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Vinayak Kapatral
Unternehmen | Position | Ende |
---|---|---|
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Corporate Officer/Principal | 10.06.2011 |
IG Assets, Inc.
IG Assets, Inc. Miscellaneous Commercial ServicesCommercial Services IG Assets products and services are based on ERGO, its web-based genome analysis platform. ERGO integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO provides better and faster identification of gene function across all organisms. Its scientists have broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. | Corporate Officer/Principal | - |
Ausbildung von Vinayak Kapatral
University of Idaho | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Integrated Genomics, Inc.
Integrated Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Founded in 1997, Chicago-based Integrated Genomics™ specializes in research in microbial genomics, biochemistry, and gene expression. Its scientists has broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. Integrated Genomics™ has particularly long-standing relationships and active research in the area of lactic acid bacteria and pathogenic microbes, as well as a broad customer base across industry, academic and government institutions. Integrated Genomics™' products and services are based on ERGO™, its web-based genome analysis platform. ERGO™ integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO™ provides better and faster identification of gene function across all organisms. In 2010 Integrated Genomics, Inc.'s business operations were transitioned to a new corporation, IG Assets, Inc. With the original Integrated Genomics' team, IG Assets continues to provide the same ERGO-based microbial genomic products and service. | Commercial Services |
IG Assets, Inc.
IG Assets, Inc. Miscellaneous Commercial ServicesCommercial Services IG Assets products and services are based on ERGO, its web-based genome analysis platform. ERGO integrates proprietary functional genomic data, metabolic reconstructions, expression profiling, and biochemical and microbiological data with publicly available information. Focused on microbial genomics, ERGO provides better and faster identification of gene function across all organisms. Its scientists have broad experience in both in silico and wet lab sequencing, research and development with more than 100 relevant publications in these areas. | Commercial Services |